dd-cfDNA Significantly Improves Rejection Yield in Kidney Transplant Biopsies

By afschroeder • August 10, 2025

Bromberg JS, Brennan DC, Taber DJ, Cooper M, Anand S, Akalin E, Huang E, Klein JA, Glehn-Ponsirenas R, Rogers J, Chuang P, Kothari AS, Shen L, Woodward RN, Kumar D, Wojciechowski D, Mandelbrot D, Costa N, Bu L, Weir MR; KOAR investigators. dd-cfDNA Significantly Improves Rejection Yield in Kidney Transplant Biopsies. Am J Transplant. 2025 Aug 6:S1600-6135(25)02875-8. doi: 10.1016/j.ajt.2025.07.2484. Epub ahead of print. PMID: 40780562.

Tags: Biopsy yield, clinical utility of dd-cfDNA, dd-cfDNA, donor derived cell free DNA, KOAR (Kidney allograft Outcomes Allosure Registry). NCT03326076, Nephrology, post-kidney transplant biopsy, Publications, Rejection yield, sub-clinical rejection, surveillance biopsy

Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients Aged 65 y or Older: Findings From a Randomized, Phase 3 Trial

Bunnapradist S, Vincenti F, Witzke O, Schneeberger S, Nguyen MH, Broyde N, Gilbert CL, Haber B. Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for[...]

Online hemodiafiltration for kidney failure: guidance and best clinical practice recommendations from the Italian Society of Nephrology

Strippoli GFM, Pellegrino G, Hegbrant J, Fabbrini P, Lentini PLM, Aucella F, Panichi V, Gallieni M, Canaud B, Davenport A, Ortiz A, Ramos R, Malyszko[...]

A literature review and reflection on clinical trials: current challenges, future directions, and potential strategies to overcome practical barriers

Zhang K, Lampridis S, Simone CB 2nd, Negoi I, Peng Y, Shang B, Lin Y, Cheng Y, Yang F, Shelat VG, Kalantar-Zadeh K. A literature[...]